Novelix Pharmaceuticals standalone net profit declines 35.71% in the March 2025 quarter
Net profit of Novelix Pharmaceuticals declined 35.71% to Rs 0.18 crore in the quarter ended March 2025 as against Rs 0.28 crore during the previous quarter ended March 2024. Sales rose 2383.33% to Rs 20.86 crore in the quarter ended March 2025 as against Rs 0.84 crore during the previous quarter ended March 2024.
For the full year,net profit rose 700.00% to Rs 0.08 crore in the year ended March 2025 as against Rs 0.01 crore during the previous year ended March 2024. Sales rose 627.96% to Rs 30.72 crore in the year ended March 2025 as against Rs 4.22 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | |
| Sales | 20.86 | 0.84 | 2383 | 30.72 | 4.22 | 628 |
| OPM % | 1.10 | 19.05 | - | 0.46 | -5.92 | - |
| PBDT | 0.23 | 0.29 | -21 | 0.16 | 0.06 | 167 |
| PBT | 0.21 | 0.28 | -25 | 0.12 | 0.02 | 500 |
| NP | 0.18 | 0.28 | -36 | 0.08 | 0.01 | 700 |